Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2013. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of a specific share transaction rather than a financial performance report.
Material Changes
The filing details a specific transaction on April 10, 2013, involving Mr. P C Thomson and his connected person, Mrs. K Thomson. Through the Company's ShareReward Plan, they acquired a total of 14 Ordinary Shares (7 under the personal contribution element and 7 under the matching element) at a price of 1535.98 pence per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the share acquisition transaction in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Transaction Date: April 10, 2013.
- Parties Involved: Mr. P C Thomson and Mrs. K Thomson (Connected Person).
- Share Price: 1535.98 pence per Ordinary Share.
- Total Shares Acquired: 14 Ordinary Shares (7 personal, 7 company match).
- Notification Date: April 11, 2013.